For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Tokushima 770-8539

0 studies enrolling now · 6 studies all time

What they study most

Alzheimer's Disease, Cardiovascular Diseases, Rheumatoid Arthritis

Studies at this site

• Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo — Stopped early
• A Study of Evacetrapib in High-Risk Vascular Disease — Stopped early
• An Open Label Study for Participants With Rheumatoid Arthritis — Stopped early
• A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate — Stopped early
• Effect of LY450139 on the Long Term Progression of Alzheimer's Disease — Completed
• A Study of Semagacestat for Alzheimer's Patients — Completed